(Q43267068)

17 November 2017

title

The evaluation and treatment of hirsute women (English)

1 reference

17 November 2017

Kursad Unluhizarci

1

1 reference

17 November 2017

Yilmaz Sahin

series ordinal

2

1 reference

17 November 2017

Fahrettin Kelestimur

series ordinal

3

1 reference

17 November 2017

publication date

1 November 2005

1 reference

17 November 2017

1 reference

17 November 2017

volume

1

1 reference

17 November 2017

issue

3

1 reference

17 November 2017

page(s)

429-435

1 reference

The clinical management of hirsutism

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Androgen excess in women: experience with over 1000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Laser hair reduction in the hirsute patient: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

The treatment of women with hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data*

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

The investigation of insulin resistance in patients with idiopathic hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Low-dose (2.5 mg/day) finasteride treatment in hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Potential utility of insulin sensitizers in the treatment of patients with Polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

Damage to hair follicles by normal-mode ruby laser pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.3.429

21 January 2018

Identifiers

DOI

10.2217/17455057.1.3.429

1 reference

17 November 2017

1 reference